Aegerion Pharmaceuticals Inc. (AEGR): Broadfin Capital Raises Its Stake Ahead of Merger
Back in June, Aegerion Pharmaceuticals Inc. (NASDAQ:AEGR), Qlt Inc.
Posts Tagged ‘NASDAQ:AEGR’
Why Aegerion Pharmaceuticals, Bank of America and Three Other Stocks are in Spotlight Today?
Markets opened higher on Wednesday as investors await the announcement regarding interest rate hike from the Federal Reserve today.
Sarissa Capital Management and Aegerion Pharmaceuticals, Inc. (AEGR) Amend Nomination Agreement
In a recent filing with the US Securities and Exchange Commission, Alex Denner's Sarissa Capital Management has reported entering into an amendment to the nomination agreement...
Pharmaceutical And LNG Stocks Are Driving The Market Higher Today
U.S. stocks look set to end today's trading session in green territory, having gone through a strong selloff last week.
These Four Stocks Are Leading Today’s Losers Pack for Various Reasons
Although the market has regained most of the losses from the opening hour, there are some stocks that have remained deep in red. Valeant Pharmaceuticals Intl Inc (NYSE:VRX), ...
Aegerion Pharmaceuticals, Inc. (AEGR): Sarissa Capital Management Files Amended 13D
Sarissa Capital Management filed an amended 13D today regarding Aegerion Pharmaceuticals (NASDAQ:AEGR) disclosing the confidentiality agreement between the activist hedge fund...
One Fund is Buying This Biotech Stock Although It’s Losing Smart Money’s Support
Alex Denner is still bullish on Aegerion Pharmaceuticals, Inc. (NASDAQ:AEGR) and has further increased his stake in the company.
Broadfin Capital Thinks ContraFect Corp (CFRX) Can Prevent 25% of Deaths
According to a recent 13G form filed with the Securities and Exchange Commission, Kevin Kotler's Broadfin Capital has initiated a stake in ContraFect Corp (NASDAQ:CFRX) to the...
Carbylan Therapeutics Inc (CBYL): Broadfin’s Latest Move and Market Smashing Q1 Returns Inside
To say Kevin Kotler’s Broadfin Capital had exceptional Q1 returns from its 11 long positions in companies valued at $1 billion or more would be a gross understatement.
Aegerion Pharmaceuticals, Inc. (AEGR), Joint Corp (JYNT), Trillium Therapeutics Inc. (TRIL): Latest Fund Moves in the Hot Healthcare Sector
At Insider Monkey, we track over 700 of the top hedge funds in the world, following and reporting on their latest moves disclosed through filings with the Securities and Exchange...
Aegerion Pharmaceuticals, Inc. (AEGR): Broadfin Boosts Stake Getting on Board with Other Bullish Investors
Kevin Kotler's New York-based fund Broadfin Capital has boosted its position in Aegerion Pharmaceuticals, Inc. (NASDAQ:AEGR).
Lumber Liquidators Holdings Inc (LL): Steve Cohen’s Point72 Seems To Love This Stock
Steve Cohen’s Point72 Asset Management disclosed today a huge increase in its stake in Lumber Liquidators Holdings Inc (NYSE:LL). The funds affiliated with Mr.
Aegerion Pharmaceuticals Inc. (AEGR), Cytori Therapeutics Inc (CYTX): Scopia Capital and Sabby Capital Are Bullish on These Stocks
Aegerion Pharmaceuticals, Inc. (NASDAQ:AEGR) continues to feel hedge funds’ bullishness.
Aegerion Pharmaceuticals, Inc. (AEGR): Steve Cohen’s Point72 Asset Management Goes Big
Life science is turning out to be an industry sector that most hedgies are convinced will outperform in the near future.
Aegerion Pharmaceuticals, Inc. (AEGR) & The GEO Group Inc (GEO): Scopia Capital Bets On Biotech Recovery, Gets Out Of Real Estate
Scopia Capital Management has disclosed in a recent regulatory filing with the Security and Exchange Commission that it has acquired 4.2 million shares of Aegerion Pharmaceuticals...
Two Healthcare Stocks That Insiders Are Buying
Over the past couple of days, the healthcare sector has witnessed plenty of insider activity, which should not be overlooked.
Billionaire Mark Kingdon’s Top Stock Picks: HCA Holdings, Delta Air Lines & Others
In the current round of 13F filings, hedge funds and other institutional investors are disclosing their equity portfolios as held at the end of the last year.
Four Reasons to Buy This Biotechnology Stock
ISIS Pharmaceuticals, Inc. (NASDAQ:ISIS), a developer and marketer of RNA-based novel drugs to treat a variety of diseases, has been one of the best performing stocks in the ...
Is Pacira Pharmaceuticals Inc (PCRX) Going to Burn These Hedge Funds?
To the average investor, there are many methods market participants can use to analyze publicly traded companies.
Alexion Pharmaceuticals, Inc. (ALXN), Pharmacyclics, Inc. (PCYC), Aegerion Pharmaceuticals, Inc. (AEGR), Raptor Pharmaceutical Corp. (RPTP): Have These Four Biotechs Peaked?
Biotechnology stocks often trade with excessive valuations, until one day, large losses occur.
Aegerion Pharmaceuticals, Inc. (AEGR): Cheers and Jeers for Amgen, Inc. (AMGN)’s Pipeline
Just after the successful acquisition of Onyx Pharmaceuticals and positive results on AMG-145, a cholesterol-lowering experimental drug, Amgen, Inc.
ISIS Pharmaceuticals, Inc. (ISIS) Scores Another Big Biotech Deal With Biogen Idec Inc. (BIIB)
Make that four collaborations between Biogen Idec Inc. (NASDAQ:BIIB) and ISIS Pharmaceuticals, Inc. (NASDAQ:ISIS) in the last two years.
Hedge Funds Are Buying Impax Laboratories Inc (IPXL)
At the moment, there are tons of indicators shareholders can use to analyze publicly traded companies.
Santarus, Inc. (SNTS), Aegerion Pharmaceuticals, Inc. (AEGR), Ariad Pharmaceuticals, Inc. (ARIA): Did a Strong New Drug Make This Biotech Overvalued?
Santarus, Inc. (NASDAQ:SNTS) has risen over 300% in the past year partly based on sales optimism for ulcerative colitis drug Uceris, which launched in the first quarter.
Is Aegerion Pharmaceuticals, Inc. (AEGR) Going to Burn These Hedge Funds?
To the average investor, there are dozens of gauges market participants can use to watch publicly traded companies.
Aegerion Pharmaceuticals, Inc. (AEGR), ISIS Pharmaceuticals, Inc. (ISIS), Sanofi SA (ADR) (SNY): This Is One Incredible CEO
The Motley Fool's readers have spoken, and I have heeded their cries.
Questcor Pharmaceuticals Inc (QCOR), ISIS Pharmaceuticals, Inc. (ISIS): Despite a Mid-Stage Disappointment, This Biotech Stock Is Still in Great Shape
As human beings it can sometimes be difficult for us to see the good in a bad situation.
Pfizer Inc. (PFE), Merck & Co., Inc. (MRK), Aegerion Pharmaceuticals, Inc. (AEGR): Will This Speculative Cholesterol Treatment Pay Off?
In America, 33.5% of adults over the age of 20 have high LDL (“bad”) cholesterol levels, according to the CDC.
ISIS Pharmaceuticals, Inc. (ISIS), Aegerion Pharmaceuticals, Inc. (AEGR): Two Drugs Competing for an One-In-A-Million Disease
Both ISIS Pharmaceuticals, Inc. (NASDAQ:ISIS) and Aegerion Pharmaceuticals, Inc.
Alexion Pharmaceuticals, Inc. (ALXN), BioMarin Pharmaceutical Inc. (BMRN): 5 of the World’s Most Ultra-Rare Diseases
There are few times when your doctor or physician will utter the phrase, "I don't know" to a patient, but when you're dealing with the rarest of diseases, then all bets are off...
Aegerion Pharmaceuticals, Inc. (AEGR), ISIS Pharmaceuticals, Inc. (ISIS), BioMarin Pharmaceutical Inc. (BMRN): Orphan Drug Makers – Robust Investment Opportunities
The US pharmaceutical industry has been revolutionized by the emerging biotech companies which have discovered new ways to cure even the rarest of diseases.
Aegerion Pharmaceuticals, Inc. (AEGR), Mosaic Co (MOS), Staples, Inc. (SPLS): 3 Stocks to Get on Your Watchlist
I follow quite a lot of companies, so the usefulness of a watchlist to me cannot be overstated.
Aegerion Pharmaceuticals, Inc. (AEGR), NPS Pharmaceuticals, Inc. (NPSP): Three of the World’s Rarest Diseases (and the Uncommon Profits They Bring)
Imagine finding out that you have a disease that only a handful of people around the world have. Kirstie and Catherine Fields don't have to imagine it.
ISIS Pharmaceuticals, Inc. (ISIS): This Anti-Sense Bet Makes Sense
In the last couple of years, the biotechnology industry has been on a roll.
VIVUS, Inc. (VVUS), ISIS Pharmaceuticals, Inc. (ISIS), Gilead Sciences, Inc. (GILD): Biotech Companies Battle It Out
Biotech companies sometimes get lucky, launching a drug into a new indication where there's no competition, but more often than not the biotech companies have to battle it out...
Aegerion Pharmaceuticals, Inc. (AEGR), Arena Pharmaceuticals, Inc. (ARNA): Investment Opportunities in Drug Launches
There are investment opportunities in every sector, but biotechs launching new drugs offer a unique investment opportunity to take advantage of hyper-growth as sales increase ...
Here is What Hedge Funds Think About Pacira Pharmaceuticals Inc (PCRX)
Is Pacira Pharmaceuticals Inc (NASDAQ:PCRX) a superb investment right now? Hedge funds are in an optimistic mood.
Arena Pharmaceuticals, Inc. (ARNA), Rigel Pharmaceuticals, Inc. (RIGL): This Week in Biotech
With the SPDR S&P Biotech Index up 38% over the trailing-12-month period, it's evident that investment dollars are willingly flowing into the biotech sector.
Aegerion Pharmaceuticals, Inc. (AEGR), MannKind Corporation (MNKD): 3 Biotech Companies You Should Have Bought This Year
If you'd owned these three biotech companies at the beginning of the year, you're sitting on around a triple compared to a relatively smaller-but-still-impressive 34% increase...
Aegerion Pharmaceuticals, Inc. (AEGR): A $90 Price Target for This Biotech! How’s It Figured?
Aegerion Pharmaceuticals, Inc.
Hedge Funds Are Betting On Aegerion Pharmaceuticals, Inc. (AEGR)
In the eyes of most market participants, hedge funds are assumed to be slow, old investment tools of yesteryear.
Why Aegerion Pharmaceuticals, Inc. (AEGR) Shares Jumped
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis...
Stewart Enterprises, Inc. (STEI), Smithfield Foods, Inc. (SFD), The Fresh Market Inc (TFM) & More: Are These Stocks Worth Buying?
We will take a quick look at four stocks that have had substantial rises in price so far today. The four stocks we will review are: Stewart Enterprises, Inc.
Hedge Funds Are Crazy About Aegerion Pharmaceuticals, Inc. (AEGR)
According to most market participants, hedge funds are assumed to be underperforming, outdated financial tools of the past.
Aegerion Pharmaceuticals, Inc. (AEGR), TESARO Inc (TSRO), And Three Humongous Healthcare Stocks This Week
Up, up, and away. That's the motto for the market as a whole so far this year, but it's also especially applicable for a select group of stocks.
Is Aegerion Pharmaceuticals, Inc. (AEGR) Now a Sell?
Shares of Aegerion Pharmaceuticals, Inc.
Regeneron Pharmaceuticals Inc (REGN), Questcor Pharmaceuticals Inc (QCOR), Aegerion Pharmaceuticals, Inc. (AEGR): Three Booming Biotech Companies
Wall Street had a great week. The Dow topped 15,000. The S&P 500 also notched a record high. But few stocks blew the doors off like those of these three biotech companies.
Amgen, Inc. (AMGN): What’s Its Next Catalyst?
Amgen, Inc. (NASDAQ:AMGN) stock has been on a bit of a roller coaster lately.
